(S)-4-Aminoisoxazolidin-3-one; Levcycloserine; Levcicloserina; Levcycloserinum; Cyclo-L-serine; UNII-AK7DRB7FMO; (S)-4-Amino-3-isoxazolidinone; L-4-Aminoisoxazolidin-3-one; (4S)-4-amino-1,2-oxazolidin-3-one; AK7DRB7FMO; L-4-Amino-3-isoxazolidinone; (S)-(-)-Cycloserine; (4S)-4-aminoisoxazolidin-3-one; L-Oxamicina [Italian]; Levcycloserine [USAN:INN]; Levcycloserinum [INN-Latin]; Levcicloserina [INN-Spanish]; EINECS 206-427-0; L-Oxamicina; (R)-4-AMINOISOXAZOLIDIN-3-ONE; (-)-cycloserine; BRN 0080799; (-)-4-Amino-3-isossazolidone [Italian]; (S)-4-Amino-3-isoxazolidone; L-Cycloserin; (-)-4-Amino-3-isossazolidone; 3-Isoxazolidinone, 4-amino-, (S)-; 3-ISOXAZOLIDINONE, 4-AMINO-, (L)-; 3-Isoxazolidinone, 4-amino-, (4S)-; Cycloserine Impurity 4; Prestwick0_001086; Prestwick1_001086; Prestwick2_001086; Prestwick3_001086; Levcycloserine (USAN/INN); Lopac0_000199; BSPBio_001132; 4-27-00-05550 (Beilstein Handbook Reference); MLS000859981; SCHEMBL243772; SPBio_003026; BPBio1_001246; CHEMBL448864; GTPL9488; (-)-4-amino-3-isoxazolidinone; (-)-4-aminoisoxazolidin-3-one; CTK8B7665; KS-00000NWI; (S)-4-amino-isoxazolidin-3-one; DTXSID701017231; HMS1571I14; HMS2098I14; HMS2235N07; HMS3260H19; HMS3264E06; HMS3715I20; (S)-3-Isoxazolidinone, 4-amino-; ACT10801; HY-B1122; Tox21_500199; 4034AB; ANW-58103; BDBM50357231; FD3007; MFCD00064324; s3945; SBB006706; ZINC34676244; AKOS006237181; CCG-204294; CS-4717; LP00199; SDCCGSBI-0050187.P002; NCGC00093674-01; NCGC00093674-02; NCGC00093674-03; NCGC00093674-04; NCGC00093674-08; NCGC00260884-01; DS-18395; SMR000326840; AB0006204; AB00514038; EU-0100199; L-Cycloserine, L-4-Amino-3-isooxazolidinone; (4S)-4-amino-2,4,5-trihydroisoxazol-3-one; (S)-4-Amino-3-isoxazolidone;(S)-Cycloserine; C 1159; D04706; AB00514038_05; 339C720; SR-01000780566; J-502461; SR-01000780566-2; Q27145415